263
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T18479 |
NH-bis(C1-Boc)
亚氨基二乙酸二异丁酯 |
Others | Others |
Boc-NH-C6-Br 是一种不可切割的接头,用于抗体-药物偶联物。 | |||
T21408 |
DM1-SMe
DM1-SSMe |
Microtubule Associated | Cytoskeletal Signaling |
DM1-SMe (DM1-SSMe) 是美登木素微管的有效抑制剂。 DM1-SMe 的效力是母体药物美登素的 3 至 10 倍,在一组人类肿瘤细胞系中,DM1-SMe 的 IC50 为 0.003 至 0.01 nM。 | |||
T14061 |
EMCS
6-Maleimidohexanoic acid N-hydroxysuccinimide ester |
Others | Others |
EMCS (6-Maleimidohexanoic acid N-hydroxysuccinimide ester) 是一种异双官能团交联剂,是一种制备半抗原结合物和酶免疫偶联物的化合物,是抗体药物偶联物中一种有效的保护基团。 | |||
T4289 |
Mc-Val-Ala-PAB
Mc-Val-Ala-PAB |
Others; AChR | Neuroscience; Others |
Mc-Val-Ala-PAB 是一种可降解的 ADC 接头,用于抗体-药物偶联物。 | |||
T76769 |
Indusatumab
|
Guanylate cyclase | GPCR/G Protein |
Indusatumab (5F9 Monoclonal antibody) 是一种 anti-human GUCY2C (Guanylate cyclase 2C) 单克隆抗体,可用于合成抗体-药物偶联物。 | |||
T1910 |
Ansamitocin P 3'
Maytansinol butyrate,Ansamitocin P-3,安丝菌素P-3,Antibiotic C 15003P3' |
Microtubule Associated | Cytoskeletal Signaling |
Ansamitocin P 3' (Maytansinol butyrate) 是一种具有抗肿瘤活性的抗体-药物偶联细胞毒素。 | |||
T16899 |
SMCC-DM1
DM1-SMCC |
Others | Others |
SMCC-DM1 (DM1-SMCC) 是一种药物-接头偶联物,由有效的微管破坏剂 DM1 和接头 SMCC 组成,用于制备抗体药物偶联物。 | |||
T77406 |
lorvotuzumab
|
Others | Others |
Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) 是一种人源化结合 CD56 (NCAM1) 的单克隆抗体。Lorvotuzumab 可用于合成抗体-药物偶联物( Lorvotuzumab mertansine)。 | |||
T16031 |
McMMAF
Maleimidocaproyl monomethylauristatin F |
Microtubule Associated | Cytoskeletal Signaling |
McMMAF 是一种保护基团共轭的 MMAF。它是一种具有马来酰亚胺基己酰基接头(MC 接头)的 MMAF 衍生物, MMAF 是一种有效的微管蛋白聚合抑制剂。它可与抗体或其他蛋白质或生物聚合物结合。 | |||
T15141 |
DM4
Ravtansine,美登素 DM4 |
Others; Microtubule Associated | Cytoskeletal Signaling; Others |
DM4 (Ravtansine)可用于制备抗体药物偶联物,是抗微管蛋白剂。 它抑制细胞分裂。 | |||
T5149 |
MC-Val-Cit-PAB
N-[6-(2,5-二氢-2,5-二氧代-1H-吡咯-1-基)-1-氧代己基]-L-缬氨酰-N5-(氨基甲酰基)-N-[4-(羟甲基)苯基]-L-鸟氨酰胺 |
Others; AChR | Neuroscience; Others |
MC-Val-Cit-PAB 是一种组织蛋白酶可裂解的 ADC 接头,用于制备抗体-药物偶联物。 | |||
T18529 |
PDEC-NB
4-Nitrophenyl 2-(Pyridin-2-Yldisulfanyl)Ethyl Carbonate |
Others | Others |
PDEC-NB (4-Nitrophenyl 2-(Pyridin-2-Yldisulfanyl)Ethyl Carbonate) 是用于抗体-药物偶联物的二硫键可切割接头。 | |||
T18870 |
Vc-MMAD
|
Others | Others |
Vc-MMAD 由 linker (Val-Cit) 和微管抑制剂 MMAD 组成。Vc-MMAD 可用于偶联抗体。 | |||
T17731L |
CL2A-SN-38 DCA 1279680-68-0(free base)
|
Others | Others |
CL2A-SN-38 DCA 1279680-68-0(free base) 是一种药物-接头偶联物,由有效的 DNA 拓扑异构酶 I 抑制剂 SN-38 和接头 CL2A 组成,用于制造抗体药物偶联物 (ADC)。CL2A-SN-38 由有效的 DNA 拓扑异构酶组成I 抑制剂 SN-38 和接头 CL2A 以制造抗体药物偶联物 (ADC)。 CL2A-SN-38 对一系列人类实体瘤类型提供显着和特异性的抗肿瘤作用。 CL2A 是一种不可切割的复杂 PEG8 和含有三唑的 PABC-肽-mc 接头。 CL2A 可通过 pH 敏感性裂解,产生旁观者效应,并通过二硫键在半胱氨酸残基处结合抗体。 | |||
T4286 |
Fmoc-Val-Ala-PAB-OH
Fmoc-Val-Ala-PAB |
Others; AChR | Neuroscience; Others |
Fmoc-Val-Ala-PAB-OH (Fmoc-Val-Ala-PAB) 是一种有用的接头,可用于制备用于靶向药物递送的抗体-药物偶联物。它还用于合成带有溶酶体可切割接头的 RGD 拟肽-紫杉醇缀合物。 | |||
T77909 |
Mirzotamab
|
||
Mirzotamab clezutoclax(ABBV-155)是一种IgG1κ型靶向CD276/B7-H3的抗体偶联物(ADC),通过与BCL抑制剂Clezutoclax结合而构成。该化合物用于参与针对复发/难治性实体瘤的紫杉烷相关研究。 | |||
T15176 |
DSS Crosslinker
|
Others | Others |
DSS Crosslinker 是一种不可切割的 ADC 连接剂,用于合成抗体-药物偶联物。 | |||
T9227 |
Val-Ala-PAB
|
Others | Others |
Val-Ala-PAB 是 Tesirine (a.k.a. SG3249) 合成的基石,Tesirine 是一种临床抗体-药物偶联物吡咯并苯二氮卓二聚体有效载荷。制备吡咯并苯二氮卓二聚体及其抗体缀合物的试剂,该试剂含有可用于治疗包括癌症在内的增殖性疾病的肽接头。 | |||
FL0195 |
N-Boc-4-hydroxy-L-proline methyl ester
|
||
N-Boc-cis-4-hydroxy-L-proline methyl ester为不可降解(non-cleavable)的ADC linker,用于抗体药物偶联体(ADCs)合成。该化合物同时作为基于烷基链(alkyl chain)的PROTAC linker,适用于PROTAC合成。 | |||
T1992 |
Mertansine
DM1,Maytansinoid DM1 |
Microtubule Associated | Cytoskeletal Signaling |
Mertansine (DM1) 是一种微管蛋白抑制剂,也是一种抗体可缀合的美登木素生物碱。它通过连接体连接到单克隆抗体上,形成抗体偶联药物。 | |||
T18702 |
DBA-DM4
|
Others | Others |
DBA-DM4 is a drug-linker conjugate for antibody-drug conjugate (ADC) synthesis, combining the tubulin inhibitor DM1 with the SPDP linker[1]. | |||
T10832 |
CL2-SN-38
|
Others | Others |
CL2-SN-38, a part of the antibody-drug conjugate (ADC), can conjugate with the anti-Trop-2-humanized antibody hRS7. SN-38 is an inhibitor of DNA topoisomerase I. | |||
T39238 |
DBM-MMAF
|
||
DBM-MMAF is a drug-linker conjugate composed of a potent antitubulin agent MMAF and a linker DBM to make antibody drug conjugate (ADC). | |||
T18504 |
Nitro-PDS-Tubulysin M
|
Others | Others |
Nitro-PDS-Tubulysin M, an ADC (Antibody-Drug Conjugate) drug-linker conjugate, exhibits potent antitumor activity. It employs Tubulysin M, a tubulin polymerization inhibitor, connected through the Nitro-PDS ADC linker. | |||
T18317 |
MCC-Modified Daunorubicinol
|
Others | Others |
Daunorubicinol, a potent antitumor drug-linker conjugate for antibody-drug conjugate (ADC) applications, utilizes Aur0101 (DNA Topoisomerase II inhibitor) connected through the ADC linker[1]. | |||
T38788 |
MC-DM1
MC-DM1 |
||
MC-DM1 is a drug-linker conjugate composed of a potent microtubule-disrupting agent DM1 and a linker MC to make antibody drug conjugate (ADC). | |||
T38682 |
Lys-Nε-SPDB-DM4
Lys-Nε-SPDB-DM4 |
||
Lys-Nε-SPDB-DM4 is a drug-linker conjugate composed of a potent a tubulin inhibitor DM4 and a linker Lys-Nε-SPDB to make antibody drug conjugate (ADC). | |||
T18304 |
Mal-VC-PAB-ABAEP-Azonafide
|
Others | Others |
Mal-VC-PAB-ABAEP-Azonafide, an ADC (antibody-drug conjugate) linker-drug conjugate, demonstrates potent antitumor activity. It incorporates Azonafide, a cytotoxin, connected through the ADC linker Mal-VC-PAB[1]. | |||
T18699 |
SNPB
|
Others | Others |
SNPB is a cleavable linker that is used for making antibody-drug conjugate (ADC). | |||
T39941 |
MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT
MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT |
||
MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT is a Camptothecin-linker. MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT is a drug-linker conjugate for antibody-drug conjugate (ADC). | |||
T17816 |
DBCO-Val-Cit-PABC-PNP
|
Others | Others |
DBCO-Val-Cit-PABC-PNP is a cleavable linker for antibody-drug conjugate (ADC) synthesis[1]. | |||
T18700 |
SPB
|
Others | Others |
SPB is a potent anti-inflammatory drug-linker conjugate for Antibody-Drug Conjugates (ADC), utilizing Xanthotoxol connected through the ADC linker. | |||
T18701 |
SPDB-DM4
|
Others | Others |
SPDB-DM4 is a drug-linker conjugate designed for antibody-drug conjugate (ADC) applications, employing the maytansine-based payload DM4 (a tubulin inhibitor) connected through a SPDB linker. This compound demonstrates significant anti-tumor efficacy. | |||
T18310 |
AZ1508
MC-Lys-MMETA |
Others | Others |
AZ1508, a tubulin inhibitor[1], serves as a drug-linker conjugate for antibody-drug conjugates (ADC) targeting breast and stomach cancer treatment. | |||
T39316 |
DGN549-L
DGN549-L |
||
DGN549-L is a DNA alkylator that facilitates antibody conjugation at lysine residues, making it suitable for antibody-drug conjugate (ADC) synthesis. | |||
T12149 |
N-Me-L-Ala-maytansinol
|
Others | Others |
N-Me-L-Ala-maytansinol used for making antibody-drug conjugate (ADC),is a hydrophobic, cell permeable payload. | |||
T39257 |
Ugodotin
|
||
Ugodotin is an antibody-drug conjugate. Ugodotin can binds IGF-1R with antitumor activity. | |||
T18463 |
NHS-C4-MTS
N-Succinimidyloxycarbonylpropyl methanethiosulfonate |
Others | Others |
N-Succinimidyloxycarbonylpropyl methanethiosulfonate (SMPM) is a non-cleavable antibody-drug conjugate (ADC) linker employed for ADC synthesis[1]. | |||
T18465 |
N3-C2-NHS ester
|
Others | Others |
N3-C2-NHS ester is a noncleavable antibody-drug conjugate (ADC) linker employed for the synthesis of ADCs. | |||
T18731 |
Sulfo-PDBA-DM4
|
Others | Others |
Sulfo-PDBA-DM4 is a drug-linker conjugate for antibody-drug conjugate (ADC) applications, combining the potent tubulin inhibitor DM4 with the gluthatione-cleavable linker Sulfo-PDBA. This configuration harnesses DM4's cytotoxic potential through Sulfo-PDBA's targeted delivery mechanism. | |||
T18802 |
Tetrazine-SS-Biotin
|
Others | Others |
Tetrazine-SS-Biotin, a cleavable ADC linker, finds utility in ADC (antibody-drug conjugate) synthesis [1]. | |||
T17385 |
Ald-Ph-amido-PEG3-C2-Pfp ester
|
Others | Others |
Ald-Ph-amido-PEG3-C2-Pfp ester is a noncleavable antibody-drug conjugate (ADC) linker that falls under the category of polyethylene glycol (PEG) linkers. | |||
T17447 |
Aminoxyacetamide-PEG3-azide
|
Others | Others |
Aminoxyacetamide-PEG3-azide is a non-cleavable 3-unit polyethylene glycol linker employed for antibody-drug conjugate (ADC) synthesis[1]. | |||
T18330 |
MC-Val-Cit-PAB-vinblastine
|
Others | Others |
MC-Val-Cit-PAB-vinblastine is a potent antitumor drug-linker conjugate for Antibody-Drug Conjugates (ADC), featuring vinblastine (a microtubule protein inhibitor) connected through the MC-Val-Cit-PAB ADC linker. | |||
T17833 |
DM4-SMCC
|
Others | Others |
DM4-SMCC, a non-cleavable drug-linker conjugate for antibody-drug conjugates (ADC), leverages the antitumor efficacy of DM4 (an antitubulin agent) through attachment with the SMCC linker, exhibiting antitumor activity[1]. | |||
T17981 |
Fmoc-Phe-Lys(Boc)-PAB-PNP
|
Others | Others |
Fmoc-Phe-Lys(Boc)-PAB-PNP is a cleavable antibody-drug conjugate (ADC) linker employed in the synthesis of ADCs. | |||
T18644 |
PTAD-PEG4-N3
|
Others | Others |
PTAD-PEG4-N3 is a cleavable four-unit polyethylene glycol (PEG) antibody-drug conjugate (ADC) linker, utilized in ADC synthesis[1]. | |||
T39164 |
MC-betaglucuronide-MMAE-1
|
||
MC-betaglucuronide-MMAE-1 is a potent antitumor drug-linker conjugate for antibody-drug conjugates (ADCs), employing MMAE (a tubulin polymerization inhibitor) connected through the cleavable ADC linker MC-betaglucuronide. | |||
T18311 |
Mc-MMAD
|
Others | Others |
Mc-MMAD, a drug-linker conjugate for antibody-drug conjugates (ADCs), incorporates the protective group maleimidocaproyl (Mc) conjugated to monomethyl auristatin D (MMAD), a potent inhibitor of tubulin. | |||
T18717 | SPDV | Others | Others |
SPDV is a cleavable antibody-drug conjugate (ADC) linker utilized in the diagnostic and therapeutic management of cancer and B cell proliferative diseases. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T4820 |
Maleimide
马来酰亚胺,2,5-Pyrroledione |
Others | Others |
Maleimide (2,5-Pyrroledione) 可用于制备荧光探针,主要用于硫醇分析物的特异性检测。它也可用于制备用于癌症研究的抗体-药物偶联物 (ADC)。 | |||
T39562 |
γ-Amanitin
|
||
γ-Amanitin an ADC cytotoxin and isolated from the mushroom. γ-Amanitin inhibits RNA polymerase II and disrupts synthesis of mRNA. γ-Amanitin shows similar effects to α-Amanitin and β-Amanitin. | |||
T73915 |
Luisol A
|
||
Luisol A 是一种芳香族四醇,是链霉菌属的河口海洋放线菌的主要代谢产物。Luisol A 是一种蒽醌抗生素类似物,是 ADC 细胞毒素 (ADC Cytotoxin)。 |